Published in Brain Res on December 15, 2005
Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake. Pharmacol Ther (2008) 1.94
Genome-wide analysis of aging and learning-related genes in the hippocampal dentate gyrus. Neurobiol Learn Mem (2008) 0.97
Social defeat stress activates medial amygdala cells that express type 2 corticotropin-releasing factor receptor mRNA. Neuroscience (2009) 0.90
Experimental gastritis leads to anxiety- and depression-like behaviors in female but not male rats. Behav Brain Funct (2013) 0.81
Fighting experience alters brain androgen receptor expression dependent on testosterone status. Proc Biol Sci (2014) 0.78
Influence of hyperthyroid conditions on gene expression in extraocular muscles of rats. Physiol Genomics (2009) 0.77
Sharing stressful experiences attenuates anxiety-related cognitive and sleep impairments. Behav Brain Res (2011) 0.76
The Mineralocorticoid Agonist Fludrocortisone Promotes Survival and Proliferation of Adult Hippocampal Progenitors. Front Endocrinol (Lausanne) (2016) 0.76
Effects of dominant/subordinate social status on formalin-induced pain and changes in serum proinflammatory cytokine concentrations in mice. PLoS One (2013) 0.75
Temporal profiling of depression vulnerability in a preclinical model of sustained depression. Sci Rep (2017) 0.75
Contribution of common genetic variants to antidepressant response. Biol Psychiatry (2012) 1.73
Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology (2006) 1.72
Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology (2007) 1.64
Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr Med Chem (2002) 1.38
Characterization of divIVA and other genes located in the chromosomal region downstream of the dcw cluster in Streptococcus pneumoniae. J Bacteriol (2003) 1.36
Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med (2012) 1.24
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis. PLoS Med (2012) 1.19
Phage-display and correlated mutations identify an essential region of subdomain 1C involved in homodimerization of Escherichia coli FtsA. Proteins (2003) 1.17
Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism. Chirality (2006) 1.16
Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Peptides (2006) 1.03
Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats. Behav Brain Res (2006) 1.03
Different susceptibility to social defeat stress of BalbC and C57BL6/J mice. Behav Brain Res (2010) 0.97
Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.95
SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test. Neuropsychopharmacology (2007) 0.93
Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment. Brain Res (2004) 0.91
Circadian profile of peripheral hormone levels in Sprague-Dawley rats and in common marmosets (Callithrix jacchus). In Vivo (2010) 0.90
Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment. Psychopharmacology (Berl) (2010) 0.90
Expression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behaviours. PLoS One (2010) 0.90
Social defeat-induced contextual conditioning differentially imprints behavioral and adrenal reactivity: a time-course study in the rat. Physiol Behav (2007) 0.89
Strain-specific outcomes of repeated social defeat and chronic fluoxetine treatment in the mouse. Pharmacol Biochem Behav (2010) 0.89
Proteome analysis of rat polymorphonuclear leukocytes: a two-dimensional electrophoresis/mass spectrometry approach. Electrophoresis (2002) 0.87
Transient forebrain over-expression of CRF induces plasma corticosterone and mild behavioural changes in adult conditional CRF transgenic mice. Pharmacol Biochem Behav (2009) 0.86
Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist. Br J Pharmacol (2005) 0.86
CRF1 receptor activation increases the response of neurons in the basolateral nucleus of the amygdala to afferent stimulation. Front Behav Neurosci (2008) 0.86
A scintillation proximity assay amenable for screening and characterization of DNA gyrase B subunit inhibitors. Anal Biochem (2002) 0.85
Intermittent exposure to social defeat and open-field test in rats: acute and long-term effects on ECG, body temperature and physical activity. Stress (2002) 0.85
Synthesis and pharmacological characterization of novel druglike corticotropin-releasing factor 1 antagonists. J Med Chem (2008) 0.85
Alterations of behavioral and endocrinological reactivity induced by 3 brief social defeats in rats: relevance to human psychopathology. Psychoneuroendocrinology (2009) 0.84
Delay of ejaculation induced by SB-277011, a selective dopamine D3 receptor antagonist, in the rat. J Sex Med (2008) 0.82
Advances in multidisciplinary and cross-species approaches to examine the neurobiology of psychiatric disorders. Eur Neuropsychopharmacol (2011) 0.80
Microarray analysis of cultured rat hippocampal neurons treated with brain derived neurotrophic factor. Mol Biol Rep (2010) 0.80
Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists. Eur Neuropsychopharmacol (2006) 0.80
6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor. J Med Chem (2010) 0.80
Proteomic analysis of rat cortical neurons after fluoxetine treatment. Brain Res (2006) 0.80
Nortriptyline influences protein pathways involved in carbohydrate metabolism and actin-related processes in a rat gene-environment model of depression. Eur Neuropsychopharmacol (2010) 0.80
Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse. Neurosci Lett (2003) 0.79
Conditioning properties of social subordination in rats: behavioral and biochemical correlates of anxiety. Horm Behav (2006) 0.79
Proteomic analysis of rat brain tissue: comparison of protocols for two-dimensional gel electrophoresis analysis based on different solubilizing agents. Electrophoresis (2002) 0.78
p38 MAP kinase activation does not stimulate serotonin transport in rat brain: Implications for sickness behaviour mechanisms. Life Sci (2013) 0.78
Regional changes in the contralateral "healthy" hemisphere after ischemic lesions evaluated by quantitative T2 parametric maps. Anat Rec (2002) 0.78
Escitalopram modulates neuron-remodelling proteins in a rat gene-environment interaction model of depression as revealed by proteomics. Part I: genetic background. Int J Neuropsychopharmacol (2010) 0.78
1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors. J Med Chem (2010) 0.78
A new integrated statistical approach to the diagnostic use of two-dimensional maps. Electrophoresis (2003) 0.78
Effect of the p38 MAPK inhibitor SB-239063 on Lipopolysaccharide-induced psychomotor retardation and peripheral biomarker alterations in rats. Eur J Pharmacol (2011) 0.77
Genetic susceptibility for bipolar disorder and response to antidepressants in major depressive disorder. Am J Med Genet B Neuropsychiatr Genet (2013) 0.77
Distinct receptor subtypes mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells. Eur J Pharmacol (2012) 0.77
Dihydropyrrole[2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: mapping of the receptor binding pocket by in silico docking studies. J Med Chem (2008) 0.77
Development of a high-throughput scintillation proximity assay for the identification of C-domain translational initiation factor 2 inhibitors. J Biomol Screen (2002) 0.77
Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.77
Escitalopram affects cytoskeleton and synaptic plasticity pathways in a rat gene-environment interaction model of depression as revealed by proteomics. Part II: environmental challenge. Int J Neuropsychopharmacol (2010) 0.77
Heteroaryl-substituted 4-(1H-pyrazol-1-yl)-5,6-dihydro-1H-pyrrolo[2,3-d]pyrimidine derivatives as potent and selective corticotropin-releasing factor receptor-1 antagonists. ChemMedChem (2008) 0.76
Quantitative analysis of two-dimensional gel-separated proteins using isotopically marked alkylating agents and matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom (2002) 0.76
Biomarkers for antipsychotic therapies. Handb Exp Pharmacol (2012) 0.76
Proteomics of rat hypothalamus, hippocampus and pre-frontal/frontal cortex after central administration of the neuropeptide PACAP. Mol Biol Rep (2011) 0.75
5-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-2(1H)-quinolinones and 3,4-dihydro-2(1H)-quinolinones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Part 3. Bioorg Med Chem Lett (2010) 0.75
Enantiomerically pure tetrahydroquinoline derivatives as in vivo potent antagonists of the glycine binding site associated to the NMDA receptor. Bioorg Med Chem Lett (2003) 0.75
Serum proteomic analysis during nicotine self-administration, extinction and relapse in rats. Electrophoresis (2008) 0.75
The characterization of a novel V1b antagonist lead series. Bioorg Med Chem Lett (2010) 0.75
Backbone 1H, 13C and 15N resonance assignment of the N-terminal 24 kDa fragment of the gyrase B subunit from E. coli. J Biomol NMR (2002) 0.75
Proteomic changes in rat serum, polymorphonuclear and mononuclear leukocytes after chronic nicotine administration. Proteomics (2005) 0.75
Discovering genetic polymorphism associated with gene expression levels across the whole genome. Conf Proc IEEE Eng Med Biol Soc (2009) 0.75